Literature DB >> 10715765

Gynaecomastia as a presenting feature of thyrotoxicosis.

W B Chan1, V T Yeung, C C Chow, W Y So, C S Cockram.   

Abstract

The association between gynaecomastia and thyrotoxicosis is well recognised. However, the reported frequency of the association is variable, partly depending upon the defining criteria used. Here we report two patients with thyrotoxicosis in whom gynaecomastia was the presenting feature. Both patients had other contributing factors, which are assumed to have predisposed to gynaecomastia. In both patients, the gynaecomastia resolved with successful treatment of the thyrotoxicosis. When gynaecomastia is a presenting, or prominent feature of thyrotoxicosis, the possibility of additional underlying pathology should be considered.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10715765      PMCID: PMC1741202          DOI: 10.1136/pgmj.75.882.229

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

1.  Mediastinal neoplasms in patients with Graves disease: a possible link between sustained hyperthyroidism and thymic neoplasia?

Authors:  Jonathan D Boyd; Ridas Juskevicius
Journal:  Thyroid Res       Date:  2012-07-23

2.  Early-onset breast disease: case of a Grave condition with a favorable prognosis.

Authors:  James E Siegler; Steven D Jones; Emad Kandil
Journal:  Int J Clin Exp Med       Date:  2012-06-15

Review 3.  Gynecomastia and hormones.

Authors:  Andrea Sansone; Francesco Romanelli; Massimiliano Sansone; Andrea Lenzi; Luigi Di Luigi
Journal:  Endocrine       Date:  2016-05-04       Impact factor: 3.633

4.  A 33-Year-Old Man with Gynaecomastia and Galactorrhea as the First Symptoms of Graves Hyperthyroidism.

Authors:  Somdul Khoohaphatthanakul; Apiradee Sriwijitkamol
Journal:  Case Rep Endocrinol       Date:  2016-12-01

5.  Bilateral gynecomastia: A rare presentation of thyrotoxicosis.

Authors:  K V S Hari Kumar; Abhishek Kumar; Roli Bansal; Richa Kalia
Journal:  Indian J Endocrinol Metab       Date:  2013-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.